Sources of tumor TF that activate coagulation and enhance thrombosis. We propose that tumor TF may cause the activation of coagulation that leads to increased levels of circulating TAT in the circulation, whereas TF-positive MPs may enhance venous thrombosis at a distal site. Tumors also release degraded TF protein (soluble TF) into the plasma.